Literature DB >> 26652388

Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process.

Somayeh Mirsadeghi1, Saeed Shanehsazzadeh2, Fatemeh Atyabi3, Rassoul Dinarvand4.   

Abstract

Superparamagnetic iron oxide nanoparticles (SPIONs) with specific surface coatings have been shown appropriate potential in the diagnosis and treatment of various brain diseases such as Alzheimer's. Comprehensive understanding of SPIONs interactions with amyloid beta (Aβ) and other amyloidogenic proteins is essential for their clinical application. SPIONs could be delivered to the target tissue under the magnetic field, while they might be influenced by the applied field. In this work, we exhibit the effect of different SPIONs (magnetized or non-magnetized with different surface charges) on the kinetics of Aβ fibrillation in aqueous solution by the aid of ThT assay. The results showed that applying of magnetic field to the SPIONs influences on the Aβ fibrillation because of its effect on the size due to surface charge. It was found that under magnetic field and high concentrations of nanoparticles (SPIONs-PEG-NH2), the Aβ fibrillation process accelerates, while at lower concentrations the fibrillation is inhibited. Furthermore, the coating charge has a considerable role in fibrillation process and the positively charged SPIONs/magnetized, at lower particle concentrations, accelerate the fibrillation compared with the negatively charged or uncharged SPIONs. This hints that SPIONs with a positive charge have dual effects on the Aβ fibrillation process. They influence on the concentration of monomeric protein in solution and thereby the nucleation time. Also, SPIONs have an effect on binding during the protein conformation.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid beta; Fibrillation; Magnetic field; Superparamagnetic iron oxide nanoparticles

Mesh:

Substances:

Year:  2015        PMID: 26652388     DOI: 10.1016/j.msec.2015.10.026

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  10 in total

1.  The membrane axis of Alzheimer's nanomedicine.

Authors:  Yuhuan Li; Huayuan Tang; Nicholas Andrikopoulos; Ibrahim Javed; Luca Cecchetto; Aparna Nandakumar; Aleksandr Kakinen; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Adv Nanobiomed Res       Date:  2020-11-26

2.  Vitamin k3 inhibits protein aggregation: Implication in the treatment of amyloid diseases.

Authors:  Parvez Alam; Sumit Kumar Chaturvedi; Mohammad Khursheed Siddiqi; Ravi Kant Rajpoot; Mohd Rehan Ajmal; Masihuz Zaman; Rizwan Hasan Khan
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

3.  Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer's disease amyloid-β protein aggregation.

Authors:  Kelly A Moore; Kayla M Pate; Deborah D Soto-Ortega; Samuel Lohse; Nicholas van der Munnik; Mihyun Lim; Kaliah S Jackson; Venetia D Lyles; Lemeisha Jones; Nisha Glassgow; Vanessa M Napumecheno; Shanee Mobley; Mark J Uline; Rahina Mahtab; Catherine J Murphy; Melissa A Moss
Journal:  J Biol Eng       Date:  2017-02-06       Impact factor: 4.355

Review 4.  Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease.

Authors:  Govindarajan Karthivashan; Palanivel Ganesan; Shin-Young Park; Joon-Soo Kim; Dong-Kug Choi
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

Review 5.  Magnetic Nanoparticles Applications for Amyloidosis Study and Detection: A Review.

Authors:  Jonathan Pansieri; Matthieu Gerstenmayer; François Lux; Sebastien Mériaux; Olivier Tillement; Vincent Forge; Benoit Larrat; Christel Marquette
Journal:  Nanomaterials (Basel)       Date:  2018-09-18       Impact factor: 5.076

6.  Enhanced Anti-tumor of Pep-1 Modified Superparamagnetic Iron Oxide/PTX Loaded Polymer Nanoparticles.

Authors:  Baoyan Wang; Weijun Wu; Hongjin Lu; Zhi Wang; Hongliang Xin
Journal:  Front Pharmacol       Date:  2019-01-22       Impact factor: 5.810

7.  α-synuclein interaction with zero-valent iron nanoparticles accelerates structural rearrangement into amyloid-susceptible structure with increased cytotoxic tendency.

Authors:  Seyedeh Sahar Tahaei Gilan; Dorsa Yahya Rayat; Twana Ahmed Mustafa; Falah Mohammad Aziz; Koorosh Shahpasand; Keivan Akhtari; Abbas Salihi; Osama K Abou-Zied; Mojtaba Falahati
Journal:  Int J Nanomedicine       Date:  2019-06-27

8.  Impact of porous nanomaterials on inhibiting protein aggregation behaviour.

Authors:  Munmun Bardhan; Sandip Dolui; Siddhi Chaudhuri; Uttam Paul; Gaurav Bhattacharjee; Manorama Ghosal; Nakul C Maiti; Debashis Mukhopadhyay; Dulal Senapati
Journal:  RSC Adv       Date:  2021-01-15       Impact factor: 3.361

Review 9.  Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer's disease: Current trends and future perspectives.

Authors:  Livia La Barbera; Emanuele Mauri; Marcello D'Amelio; Manuele Gori
Journal:  Front Neurosci       Date:  2022-08-04       Impact factor: 5.152

Review 10.  Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles.

Authors:  Yamir Islam; Andrew G Leach; Jayden Smith; Stefano Pluchino; Christopher R Coxon; Muttuswamy Sivakumaran; James Downing; Amos A Fatokun; Meritxell Teixidò; Touraj Ehtezazi
Journal:  Adv Sci (Weinh)       Date:  2021-03-15       Impact factor: 16.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.